Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Open-market sale Director sold 35,340 shares at an average $5.35 ($189,097)
  2. 4 Open-market sale Director sold 4,000 shares at an average $4.97 ($19,882)
  3. 4/A Open-market buy Director bought 24,000 shares at an average $0.73 ($17,618)
  4. 4/A Open-market buy Director bought 11,000 shares at an average $0.76 ($8,314)
  5. 4/A Open-market buy Director bought 39,000 shares at an average $0.78 ($30,274)
  6. 4 Open-market sale Director sold 33,669 shares at an average $4.79 ($161,388)
  7. 4 Open-market sale Director sold 20,200 shares at an average $4.69 ($94,742)
  8. 4 Open-market sale Director sold 18,400 shares at an average $4.78 ($87,938)
  9. 4 Open-market sale Director sold 82,138 shares at an average $5.16 ($424,027)
  10. 4 Open-market sale Director sold 13,000 shares at an average $5.09 ($66,150)
  11. 4/A Open-market sale Director sold 28,612 shares at an average $5.05 ($144,460)
  12. 4 Open-market sale Director sold 15,138 shares at an average $5.00 ($75,718)
  13. 4 Open-market sale Director sold 50,000 shares at $3.66 ($183,080)
  14. 4 Gift President and CEO gave 10,000 shares (gift)
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 23 of 24 · 475 filings